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Título: Validación psicométrica de la Environmental Reward Observation 
Scale (EROS) en supervivientes de cáncer de mama 
Resumen: La pérdida de gratificaciones, como resultado de la enfermedad 
y tratamiento oncológico, se relaciona con problemas emocionales en su-
pervivientes.  Environmental Reward Observation Scale (EROS) es una 
escala para evaluar reforzamiento ambiental, desarrollada a partir de mode-
los conductuales que muestran la relación entre reforzamiento ambiental y 
estado emocional. Este estudio valida esta escala con supervivientes de 
cáncer de mama y analiza su utilidad para discriminar entre supervivientes 
con y sin trastornos emocionales. Un total de 219 mujeres supervivientes 
(Medad = 52.97; DTedad = 7.50) completaron medidas de reforzamiento am-
biental, activación y evitación conductual, y estado emocional. Los datos se 
ajustan a una estructura esencialmente unidimensional, mostrando una 
consistencia interna elevada y de moderadas a altas con todas las medidas 
empleadas. Fueron estadísticamente significativas las diferencias en las 
puntuaciones entre participantes con y sin trastorno emocional. Mediante 
curvas ROC se estableció el punto de corte óptimo para discriminar ansie-
dad y depresión. Aplicando la Teoría de Respuesta al Ítem, se encontró 
que todos los ítems muestran un poder de discriminación de moderado a 
alto para evaluar reforzamiento ambiental.  La EROS se presenta como 
una medida fiable y válida que puede emplearse para mejorar la evaluación 
del estado emocional de supervivientes oncológicos.  
Palabras clave: Supervivientes, Cáncer, Environmental Reward           
Observation Scale (EROS); Depresión, Ansiedad. 
  Abstract: The loss of rewards resulting from oncological disease has been 
associated with emotional problems in cancer survivors. The                
Environmental Reward Observation Scale (EROS) evaluates                 
environmental reinforcement and is based on behavioral models which 
show the relationship between environmental reinforcement and        
emotional state. The aim of this study is to analyze the psychometrical 
properties of this scale in breast cancer survivors and its usefulness in   
discriminating between survivors with and without emotional disorders. A 
total of 219 women survivors (Mage = 52.97; SDag = 7.50) completed 
measures of environmental reinforcement, behavioral activation and 
avoidance, and emotional state. Data fit an essentially unidimensional 
structure, showing high internal consistency and correlations, varying from 
moderate to high, with all the measures used.  In the EROS scores,       
statistically significant differences were found between participants with 
and without emotional disorders. Optimum cut-off point to discriminate      
between anxiety and depression was established via Receiver Operating 
Characteristic curve. Using the framework of the Item Response Theory 
model, all the items were found to have a power of discrimination for 
measuring environmental reinforcement ranging from moderate to high. 
The EROS is a psychometrically sound instrument, which can be used to 
improve assessment of emotional state in breast cancer survivors.  
Keywords: Cancer survivors; Environmental Reward Observation Scale 
(EROS); Depression; Anxiety. 
 
Introduction 
 
Most cancer survivors adjust well to life after cancer but 
some experience emotional disorders. Anxiety and depres-
sion are the most frequent problems, with a prevalence     
superior to that found in healthy control groups (Yi &     
Syrjala, 2017). It is common for cancer survivors, having 
completed oncological treatment, to suffer from physical 
complaints, tiredness and a reduction in attention span and 
ability to concentrate. These or other physical repercussions       
frequently lead to patients reducing their involvement in    
relevant roles and/or pleasant activities (Cataldo & Brodsky, 
2013; Fernández, Padierna et al., 2011). Moreover, when 
faced with the oncological process and fear of cancer        
recurrence, survivors frequently experience unpleasant 
thoughts, feelings and memories (McGinty, Small, Laronga, 
& Jacobsen, 2016). A common reaction to these experiences, 
encouraged and reinforced by the cultural context, is to try 
to avoid them. These attempts not only do not achieve the 
desired relief but generate more discomfort, contribute to 
perpetuating it, and limit involvement in important areas of 
life (Bardeen, 2015). Distancing oneself from day-to-day    
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activities reduces the chances of maintaining contact with the 
rewarding situations and valuable conditions of life. This   
situation may be at the root of their emotional problems 
(González-Fernández et al., 2017). 
The behavioral theories of depression posit that decrease 
in access to environmental rewards and/or the                   
reinforcement of depressive behaviors and the punishment 
of healthy ones are causal factors predicting the beginning 
and the maintenance of clinical depression (Lewinsohn, 
1974). The relationship between response-contingent       
positive reinforcement (RCPR) and emotional distress has 
been established (Cuijpers, van Straten, & Warmerdam, 
2007; Manos, Kanfer, & Bush, 2010); in particular, a low   
level of RCPR is one of the critical predictors of clinical   
depression. Lewinsohn, Sullivan and Grosscup (1980)       
explain the decrease in RCPR as a consequence of the    
combination of the following conditions: a decrease in the 
number of reinforcement events; a decrease in the          
availability of these reinforcers in the environment; the      
absence of appropriate instrumental behaviors to experience 
gratifying contingencies; and an increase in exposure to   
aversive environmental experiences. For many cancer       
survivors, these four conditions are assimilated in their own 
experience of the oncological process. In line with this   
model, behavioral treatments for depression have been     
developed to facilitate increased access to reward while     
decreasing the intensity and frequency of punishing events 
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(Lewinsohn, 1974). Currently, Behavioral Activation (BA) is 
a behavioral intervention for depression that shows promise 
in effectively treating depression by increasing goal and    
value-based activity levels, thereby eliciting increased         
response-contingent reinforcement (Lejuez, Hopko, Acierno, 
Daughters, & Pagoto, 2011; Martell, Adis, & Jacobson, 
2001). The use of BA in treating emotional problems in    
cancer patients has   also been supported by controlled    
studies (Fernández, Villoria, Fernández, González, & Pérez, 
2017; Hopko et al., 2013; 2008; 2003).  
In order to assess the relationship between RCPR and 
emotional state, it is vital to carry out an objective and valid 
evaluation of the former. During the therapy, observation 
and behavior reports (e.g. daily diaries, activity schedules, 
home observations) represent invaluable strategies with     
regard to programming activities aimed at recovering         
reinforcement (Hopko & Mullane, 2008). However, it is not 
easy to measure RCPR directly as this involves observation 
of relevant behaviors in the person’s day-to-day environment 
over extended periods of time (Manos et al., 2010). Those 
researchers who have developed measures of RCPR have   
focused on measuring environmental rewards and exposure 
to pleasurable events. With the same objective in mind, Ar-
mento and Hopko (2007) developed the Environmental Reward 
Observation Scale (EROS). This scale is intended to be a proxy 
measure of RCPR by assessing the subjective experience of 
reinforcement. Items were designed to evaluate RCPR      
according to the formulation of Lewinsohn (1974). In its 
original version, with a sample of American students, the 
scale showed a unidimensional structure. Compared to 
commonly used depression and anxiety measures, as Beck 
Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996), 
The Center for Epidemiologic Studies Depression Scale 
(CESD; Radloff, 1977), or The State-Trait Anxiety Inventory 
(STAI; Spielberger et al., 1983), correlations with the EROS 
ranged between medium and large. In other validation    
studies which included the general population and also    
populations with emotional disorders, carried out with     
participants who were Spanish (Barraca & Pérez-Álvarez, 
2010), Colombian (Valderrama-Díaz, Bianchi-Salguero, & 
Villalba-Garzón, 2016), or French-speaking Belgians 
(Wagener & Blairy, 2015), in all cases there were found to be 
appropriate levels of internal consistency and also consistent 
validity evidence of internal structure. These findings        
indicate that the EROS could be a valid tool of                 
environmental reinforcement, is congruent with the          
behavioral theories of depression and can facilitate the         
implementation and measuring of BA interventions. Indeed, 
the EROS has been used both to measure the notion of    
environmental reinforcement (Becoña et al., 2017; MacPher-
son et al., 2010), and to evaluate the effect of behavioral 
treatment of emotional disorders in subjects with health 
problems (Bombardier et al., 2017). In oncological          
populations, the EROS has been used when carrying out   
behavioral interventions and as a measure of the efficacy of 
Behavioral Activation in the treatment of emotional          
disorders (González-Fernández, Fernández-Rodríguez, Paz-
Caballero & Pérez-Álvarez, 2018; Lejuez et al., 2011, 2001). 
Despite this, and despite its evident usefulness, the EROS 
has not, however, been validated with this population.  
Given this fact, the aim of this study is to obtain data    
regarding the reliability and validity evidence of the Spanish 
version of the EROS in a representative and relatively     
numerous sample of breast cancer survivors. At the same 
time, given the aforementioned peculiarities of populations 
of cancer survivors, the study also aims to analyze the      
sensitivity, specificity and ability of this scale to discriminate 
between survivors with and without depressive disorders.  
 
Method 
 
Participants  
 
The participants recruited as cancer survivors attended 
the Oncology Department of the San Agustin Hospital 
(Avilés, Spain) or the Radiotherapy Department of the Cen-
tral University Hospital of Asturias (Oviedo, Spain) for a 
scheduled medical review. The following inclusion criteria 
were established: breast cancer survivors, aged between 18 
and 70 years, whose clinical situation was that of an          
oncological disease-free stage, confirmed by up-to-date   
medical report. The exclusion criterion was physical and/or 
cognitive deterioration which might hinder understanding 
and completing of measuring instruments. 
The sample was made up of 219 women, aged between 
31 and 67 years of age (M = 52.97; SD = 7.50). Regarding 
marital status, 72.6% were married/living with their partner, 
24.7% single/divorced and 2.6% widows. Only 9.3% lived 
alone and the rest lived with relatives. All the participants 
had undergone surgery, 82.5% had received hormonal   
treatment, 80% had received radiotherapy and 57.2%          
chemotherapy. The time elapsed since the end of treatment 
ranged from 1 month to 8 years. 
 
Instruments 
 
Environmental Reward Observation Scale (EROS; Armento & 
Hopko, 2007). The EROS is a 10-item self-administered 
questionnaire answered using a 4-option Likert, where 1   
implies totally disagree and 4 means totally agree. which supplies 
information regarding the quantity and availability of         
reinforcement received from the patient’s environment. It 
was designed to evaluate the RCPR according to the       
formulation of Lewinsohn (1974). The items evaluate both 
the number of events that are potentially reinforcing and the 
availability of reinforcement in the environment (e.g., “A lot 
of activities in my life are pleasurable”, “Activities that used to be 
pleasurable are no longer gratifying”, “My life is boring”), and the 
competence of the subject to obtain reinforcement from the 
environment (e.g., “It is easy for me to find enjoyment in my life”, 
“I am satisfied with my accomplishments”, “The activities I engage in 
usually have positive consequences”). In its original version (Ar-
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mento & Hopko, 2007), it showed a unidimensional       
structure with adequate internal consistency ( = .85) and 
correlations, from moderate to strong, with different        
depression and anxiety scales (BDI-II = -.78; CESD = - .79; 
STAI-T = -.71; STAI-S = -.80). Here, the Spanish version of 
the EROS was used (Barraca & Pérez-Álvarez, 2010), for 
which data is available confirming its adequate reliability (α = 
.86) and validity evidence in relation to other variables (sig-
nificant correlations with the BDI-II = - .73; STAI-S = -.80; 
STAI-T = -.70; BADS-T = .69) and power to discriminate 
between clinical and non-clinical population. 
Behavioral Activation for Depression Scale (BADS; Kanter, 
Mulick, Busch, Berlin, & Martell, 2007). Consists of 25 items 
measuring four dimensions: Activation, Avoidance /       
Rumination, Work/School Impairment and Social Impair-
ment. The emphasis is placed on behaviours that are directed 
toward the accomplishment of goals that the individual has 
determined to be important in each area. The scale provides 
scores for each of the dimensions and also a total score. 
High scores in Activation and in the total score show a   
higher level of activation, whilst higher scores in the other 
dimensions indicate greater avoidance patterns. The total 
score demonstrated acceptable internal consistency (α = .79). 
The internal consistency for each subscale was also           
acceptable. Initial validity evidence of internal structure was 
established through significant correlations in the expected 
directions with different depression, anxiety and behavioral 
activation scales. The Spanish adaptation of the BADS (Bar-
raca, Pérez-Álvarez, & Lozano-Bleda, 2011) proved to be 
valid (significant correlations with the BDI-II = - .63; STAI-
S = -.68; STAI-T = -.70; EROS = .69) and had adequate     
internal consistency (between α = .76 and α = .90). Factor 
analysis confirmed the four-dimensional structure of the 
original instrument. 
Acceptance and Action Questionnaire - II (AAQ-II; Bond et 
al., 2011). This is a 7-item, self-rating questionnaire designed 
to measure experiential avoidance and psychological          
inflexibility. The items reflect an unwillingness to experience 
unwanted emotions and thoughts and the inability to be in 
the present moment and behave towards values-directed    
actions when experiencing psychological events that could 
undermine them. High scores indicate a greater degree of 
experiential avoidance and psychological inflexibility. The 
AAQ-II showed adequate internal consistency ( = .84), and 
also demonstrates appropriate discriminant validity          
(correlations ranged between .60 and .82 with different     
depression, anxiety and behavioral activation scales). The 
Spanish translation of this questionnaire showed adequate   
internal consistency (α = .88) and scores showed significant 
correlations with general scales measuring                        
psychopathological state and quality of life (Ruiz, Langer-
Herrera, Luciano, Cangas, & Beltrán, 2013). 
Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983) is a 14-item scale with 2 subscales, Anxiety 
(HADS-A) and Depression (HADS-D). In the depression 
and anxiety subscales, scores of 8-10 indicate probable cases 
and scores over 10 indicate clinical cases. For anxiety 
(HADS-A) this gave a specificity of .78 and a sensitivity of 
.90. For depression (HADS-D) this gave a specificity of .79 
and a sensitivity of .83. Compared to commonly used       
depression and anxiety measures (BDI-II, CESD, STAI-T) 
correlations with the HADS-D and HADS-A ranged         
between .60 and .80 (Smarr & Keefer, 2011). In psycho-
oncology, the HADS score has been proven to be an        
accurate instrument in identifying cancer patients with      
depression and anxiety (Walker et al., 2007). 
18-item Brief Symptom Inventory (BSI-18; Derogatis, 2001) 
was specifically developed as a highly sensitive and efficient 
screen for psychological distress. Consists of 18 items.      
Responses to the items allow scores to be obtained in 3    
dimensions (Somatization, Depression and Anxiety) and a 
Global Severity Index (GSI), which resumes the general level 
of psychological distress. The inventory presents satisfactory 
reliability indexes (specifically Cronbach's α), both for the 
dimensions (ranging from .74 to .84) and for the General 
Distress Index (.89). A T score ≥ 63 in the GSI or in two of 
the dimensions indicates a clinical case. Several studies show 
adequate reliability and validity of the inventory and endorse 
its use with Spanish samples (Galdón et al., 2008). 
Short form of the 1978 Beck Depression Inventory (BDI-IA) 
based on the cognitive-affective subscale (BDI-IA-SCA; 
Beck & Steer, 1993). Consists of the first thirteen items of 
the BDI-IA, referring to affective-cognitive symptoms of 
depression. Beck and Steer (1993) recommended its use 
when evaluating depression in patients with medical        
conditions. This instrument showed an adequate degree of 
criterion-related validity when distinguishing between those 
hospitalized patients with medical conditions who were and 
were not suffering from depressive disorders. Sanz and Gar-
cía-Vera (2007) found alpha coefficients > .70 in three    
Spanish samples and an acceptable index of diagnostic     
precision (area under the ROC curve = .81).   
 
Procedure 
 
Over a 6-month period, a consecutive preselection of 
cancer survivors was made from patients with a scheduled 
hospital appointment. All those women who fulfilled the   
selection criteria were informed, verbally and in writing, of 
the objectives and procedures of the study and of the     
guarantees regarding confidentiality in the evaluation and 
treatment of data. They were then asked to give their written 
consent. Each participant filled in the evaluation tests        
individually. All the participants, in line with a written       
protocol, were given the same instructions. The evaluation 
room was suitable, in terms of facilities and privacy, to allow 
the tests to be carried out adequately. None of the           
participants received additional help to fill in the             
questionnaires. The tests took approximately 20-30 min. The 
subjects received no remuneration for participating in the 
study.  
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Statistical and Psychometric Analysis  
 
Data quality was assessed in terms of mean with         
confidence interval, variance, percentage of missing data, and 
extent of ceiling and floor effects. Floor and ceiling effects 
between 1% and 15% were defined as optimal (McHorney & 
Tarlov, 1995). 
To analyze the internal structure of EROS, a             
Confirmatory Factor Analysis (CFA) was conducted because 
of previous dimensionality confirmed among several studies 
and the absence of cross-loading factors based on the       
hypothesis of unidimensionality (Lloret-Segura, Ferreres-
Traver, Hernández-Baeza, & Tomás-Marco, 2014). Given 
the difficulty in predicting all the empirical relationships that 
may exist between the items, the Modification Indices (or 
measurement errors) were taken into account in order to 
find the best fit of the data to the model.  As the original 
EROS states, a one-dimensional structure was proposed 
(Armento & Hopko, 2007). All variables were categorical. 
Therefore, Weighted Least Squares Means and Variance    
adjusted estimation (WLSMV) was used as the extraction 
method (Muthén & Muthén, 2012). The evaluation of the 
goodness of fit of the data to the model was performed via 
the χ2 divided by degrees of freedom, Root Mean Squared 
Error of Approximation (RMSEA), and Comparative Fit   
Index (CFI). Acceptable fitting models are achieved when 
the coefficient χ2/degrees of freedom is lower than 3, 
RMSEA ≤ .06, CFI ≥ .90, and SRMR ≤ .08 (Asparouhov & 
Muthén, 2009). In the present study, adequate model fit was 
assumed if at least two of these fit indices supported model 
fit (Mosewich, Hadd, Crocker, & Zumbo, 2013). CFA was 
carried out using software Mplus 7.3 (Muthén & Muthén, 
2012).  
Closeness to unidimensionality was assessed through 
Unidimensional Congruence (UniCo), Explained Common 
Variance (ECV), and Mean of Item Residual Absolute   
Loadings (MIREAL) based on Pearson product-moment 
correlation matrix (Ferrando & Lorenzo-Seva, 2014).        
Attending to standards, UNICO’s values larger than .95, 
ECV’s values larger than .85, and MIREAL’s values lower 
than .30 suggest that data can be treated as essentially       
unidimensional (Lorenzo-Seva & Ferrando, 2017).           
Additionally, a standardized solution is graphically            
represented. Cronbach’s α coefficient was used to estimate 
the reliability of each subscale.  
In the framework of Item Response Theory models 
(IRT), the Samejima’s Graded Response Model (GRM) was 
used (Samejima, 1970). The slope (discrimination parameter, 
a) and threshold (difficulty parameter, b) were estimated.  
According to Baker (2001), a values ranging between 0.01-
0.24 are very low, 0.25-0.64 are low, 0.65-1.34 are moderate, 
1.35-1.69 are high, and above 1.7 are very high. While a-
parameter shows discrimination power of the item, b-
parameter represents, for a given level of the trait (θ), the 
probability of selecting a specific response category or     
higher. The difference between the values of these            
parameters (b3 − b1) can be interpreted as an indicator of the 
ease with which a person may change his or her response 
from one category to another. Furthermore, the Information 
Function (IF) was estimated, showing the measurement     
accuracy of the instrument across different levels of trait (i.e.                
reinforcement received from the patient's environment). 
When observing IF, the solid line represents the information 
provided by the instrument, while the dotted line represents 
the standard error on the measurement. To study the         
relationships between EROS and the other variables of the 
study, Pearson’s correlation was carried out. 
Fit of the data to the normal distribution was tested using 
the Kolmogorov-Smirnov-Lilliefors test. A study of          
differences was performed based on clinical-non clinical cut-
off points on the HADS instrument. Owing to the violation 
of the assumption of normality, Mann-Whitney U test was     
carried out (CL=95%), using Cliff’s Delta as effect size     
because of non-normal distribution.  
A Receiver Operating Characteristic (ROC) curve was 
plotted to analyze the ability of the test to correctly classify 
those with and without emotional distress. Area under the 
curve (AUC) was estimated to determine the overall         
performance of the instrument to discriminate between 
those subjects with and without distress, where an area of 1 
represents a perfect test. Estimation of optimal cut-off 
points were based on the relative costs of false negative and 
false positive results (Halpern, Albert, Krieger, Metz, & 
Maidment, 1996). 
 
Results 
 
Data quality analysis 
 
Comparing all items means and standard deviations are 
like almost all the items except items 5 and 7. The item       
response was high with a small number of missing answers 
(1.4–1.8%). Floor effect was small in almost all the items 
(range 2.3–14.4% in eight out of ten cases. Floor effects were 
found in the cited items 5 and 7) and all items had a ceiling 
effect larger than 15% (range 18.6–56.3%), and all the       
response choices were used in all items. 
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Table 1. Data quality analysis. 
 
Mean 
Confidence Interval (95%) 
Variance Missing (%) Floor (%) Ceiling (%) 
Item 1 3.219 (3.05-3.39) 0.952 1.8 7.4 52.6 
Item 2 3.093 (2.90-3.29) 1.210 1.4 14.4 50.9 
Item 3 2.874 (2.70-3.05) 1.003 1.8 10.7 34.4 
Item 4 3.028 (2.84-3.21) 1.097 1.4 12.0 44.0 
Item 5 2.433 (2.21-2.65) 1.557 1.8 36.3 29.8 
Item 6 3.093 (2.90-3.29) 1.266 1.4 14.4 53.7 
Item 7 2.372 (2.16-2.59) 1.536 1.8 36.3 28.8 
Item 8 3.102 (2.93-3.27) 0.920 1.4 8.3 43.5 
Item 9 3.200 (3.02-3.38) 1.016 1.8 10.7 52.6 
Item 10 3.233 (3.09-3.37) 0.653 1.8 2.3 44.2 
 
Psychometric properties of the EROS  
 
First of all, validity evidence based on internal structure 
was checked via CFA, showing the following indexes: χ2/df 
= 3.90; CFI = .95; RMSEA = .116 [.096 - .137; CL = 90%]; 
UniCo = .896; ECV = .819; MIREAL = .270. Additionally, 
factor loadings of each item, and measurement errors          
(represented by a double-headed arrow) are shown in Figure 
1. This unidimensional solution shows a reliability coefficient 
of α = .91.  
 
Figure 1. Standardized solution of unidimensional model of EROS. 
 
IRT Analysis 
 
Parameters a and b were estimated for the EROS         
instrument (Table 2). As can be seen, all items have a     
moderate to very high discrimination power (a-parameter). 
More specifically, half of the items exhibit a very high      
discrimination (values larger than 1.7). In relation to b-
parameters, when using Samejima’s GRM, the number of b-
parameters derives from 1 minus the number of alternatives 
for that item. As there are four alternatives for the items in 
the EROS, there are three b-parameter values for each item. 
The largest differences (b3 − b1) in the EROS were found in 
items 10 and 2, and the smallest differences correspond to 
items 5, 9 and 6.  
 
Table 2. Item Response Theory (IRT) parameter estimates for               
Environmental Reward Observation Scale (EROS). 
Items a b1 b2 b3 b3 - b1 
1 2.23 -1.80 -0.90 -0.05 1.75 
2 0.72 -2.79 -1.71 -0.15 2.64 
3 3.13 -1.35 -0.36 0.49 1.84 
4 2.71 -1.36 -0.57 0.21 1.57 
5 1.65 -0.49 0.03 0.77 1.26 
6 1.59 -1.51 -0.74 -0.12 1.39 
7 1.03 -0.65 0.24 1.06 1.71 
8 1.97 -1.78 -0.79 0.25 2.03 
9 2.94 -1.38 -0.85 -0.06 1.32 
10 0.95 -4.26 -1.81 0.35 4.61 
Note: a = discrimination parameter; b1, b2, b3 = difficulty parameters. 
 
Regarding the measurement precision of the EROS, the 
IF exhibits maximum information between -1.5 and 0.5 trait 
levels, with the accuracy diminishing particularly in            
individuals with a latent trait level above +1 (Figure 2). 
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Figure 2. Environmental Reward Observation Scale Information Function. 
 
Validity evidence in relation to other variables  
 
Table 3 shows the Pearson correlations between the 
EROS and the rest of the instruments described previously, 
considering their subscales in those cases in which the       
instruments are multidimensional. Medium to large           
correlations were found between the EROS and almost all 
the dimensions assessed in this sample.  
 
Table 3. Pearson correlation coefficients between the Environmental     
Reward Observation Scale (EROS)and scales of anxiety, depression, general 
distress and psychological flexibility. 
 EROS 
AAQ-II  -.723** 
BADS-Activation .436** 
BADS-Avoidance/Rumination  -.539** 
BADS-Work/School Impairment  -.570** 
BADS-Social Impairment -.588** 
BADS-Total .727** 
BDI-IA-SCA -.667** 
BSI-18-Somatization -.346** 
BSI-18-Depression -.631** 
BSI-18-Anxiety  -.535** 
BSI-18- Global Severity Index  -.581** 
HADS-Anxiety -.608** 
HADS-Depression -.727** 
HADS-Total -.724** 
Note: p < .001 = (**). AAQ-II: Acceptance and Action Questionnaire–II. 
BADS: Behavioral Activation for Depression Scale. BDI-IA-SCA: Short 
form of the 1978 Beck Depression Inventory (BDI-IA) based on the     
cognitive-affective subscale. BSI-18: Brief Symptom Inventory.  HADS: 
Hospital Anxiety and Depression Scale. 
 
Study of differences based on clinical and non-clinical condition 
 
As assumption-of-normality-test was not confirmed (p < 
.001), a Mann-Whitney U-test was carried out to analyze    
statistically significant differences in the EROS scores of the 
participants. Participants were split into two subsamples 
(clinical and non-clinical groups) based on the standard 
HADS cut-off point. On the basis of the HADS instrument, 
statistically significant differences were found between both 
groups in anxiety (p < .001; δ = 0.66), depression (p < .001; δ 
= 0.92) and total HADS score (p < .001; δ = 0.62). As can be 
seen, effect sizes were medium for anxiety and total HADS 
score, while this effect is especially large related to the      
depression subscale.  
 
Estimation of diagnostic-test sensitivity and specificity 
 
Clinical instruments require the establishment of a cut-
off point from continuous data, which will give information 
about sensitivity and specificity of the instrument. To 
achieve this, ROC curve and AUC were carried out to       
analyze sensitivity, specificity and overall performance of the 
EROS, using the HADS as gold standard to define the      
dichotomous true clinical state. From the results obtained, 
the overall performance can be considered to range from 
good to very good: Anxiety (AUCanxiety = .832 [.767-.897; CL 
= 95%]), Depression (AUCdepression = .958 [.930 - .985; CL = 
95%]), and Total Score (AUCtotal = .809 [.743 - .874; CL = 
95%]).  
When estimating the optimal cut-off points of the EROS 
based on the gold standard established, the following results 
were found in terms of sensitivity and specificity of the      
instrument. For the HADS anxiety subscale, a score of 29 
points can be defined as the optimal cut-off point, showing a 
sensitivity of 74.80% and specificity of 80.00%. Regarding 
the HADS depression subscale, a score of 25 points can be 
defined as the optimal cut-off point, showing a sensitivity of 
82.70% and specificity of 100.00%. For the total HADS 
score, 33 points can be defined as the optimal cut-off point, 
showing a sensitivity of 70.60% and specificity of 81.70%.  
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Discussion  
 
The emotional problems of cancer survivors have been      
related to a progressive loss of rewards resulting from        
adverse experiences in the oncological process. With this in 
mind, the aims of this study were, firstly, to determine 
whether the Environmental Reward Observation Scale is a 
valid and reliable instrument for evaluating the notion of   
environmental reinforcement in breast cancer survivors and, 
secondly, to examine the capacity of this scale to               
discriminate between survivors with and without depressive         
disorders.  
With a clinically and socio-demographically                
representative sample of breast cancer survivors containing 
an adequate representation of participants with and without 
emotional disorders, the results obtained confirm the       
psychometric guarantees of the EROS in this population.  
Regarding evidence of construct validity, the confirmatory 
factor analysis indicates the unidimensionallity of the scale. 
This result coincides with those reported by Armento and 
Hopko (2007) and by other validation studies (Barraca & Pé-
rez-Álvarez, 2010; Valderrama-Díaz et al., 2016; Wagener & 
Blairy, 2015). It should be noted that, in our study, most of 
the fit indexes were observed to be below the standard     
criterion, and only the MIREAL and CFI indexes can be        
considered appropriate. The literature in general               
recommends a flexible approach to evaluating overall model 
fit, using a global analysis rather than a strict reliance on    
arbitrary cut-off values that may not be relevant to the      
specific research context (West, Taylor, & Wu, 2012).      
Consequently, in this case, considering fit indexes as a whole, 
the adequate factor loading shown by all items, the adequate 
reliability, which demonstrates a high relationship between all 
the items, and the fit indexes found in other papers, it seems 
plausible to define EROS as an essentially unidimensional   
instrument. It is, therefore, a test with sufficient                
psychometric guarantees, in the field of Psycho-oncology, 
for use in research into the relationships between the loss of 
response-contingent positive reinforcement and depression 
(Hopko et al., 2003; Lewinsohn, 1974; Martell, Addis, &    
Jacobson, 2001). 
With regard to the reliability of the test, it is to be        
underlined that this was greater than that found in the 
aforementioned previous validation studies. Not only was 
there found to be a high relationship between the individual 
items, but also, when analyzed within the Item Response 
Theory, all have a moderate to very high power of             
discrimination regarding the perception of available          
environmental reinforcement of breast cancer survivors. 
Those items which would allow a particularly precise        
differentiation between survivors with a greater or lesser    
subjective perception of environmental reinforcement are: 
“In general I am very satisfied with the way I spend my time (item 3)”, 
“My life is boring (item 9)”, “It is easy for me to find enjoyment in my life 
(item 4)”, “A lot of activities in my life are pleasurable (item 1)”. As 
might be expected, these items are the ones which have the 
highest factor loadings and item-test correlations (>.80). It 
should be pointed out that, in line with    Lewinsohn’s    
formulation of RCPR (Lewinsohn, 1974), these items would 
be evaluating both the quantity and potential availability of 
environmental reward (items 9 and 1) and the competence of 
the person to obtain reinforcement from her environment 
(items 3 and 4). These results offer further evidence of the 
consistency of the concept of RCPR. Furthermore, in light 
of the relationship existing between emotional state and 
RCPR (Cuijpers, van Straten, & Warmerdam, 2007; Manos et 
al., 2010), they would support the effectivity ofbehavioral   
interventions aimed at increasing reinforcement in order to 
reduce levels of emotional distress. With regard to future 
studies, the question arises as to whether evaluating only 
those items which have shown the greatest discriminatory 
capacity may be sufficient in order to make a precise          
estimation of the survivor’s subjective perception of         
environmental reinforcement. If this were so, it would be 
possible to elaborate a briefer instrument and reduce       
evaluation time. The test would in turn be made simpler and 
more efficacious.  
In the analysis of those items with the smallest b3-b1       
difference values, it is also worth noting that the conditions 
which appear to be most susceptible to change are: “Other 
people seem to have more fulfilling lives (item 5)”, “My life is boring (item 
9)”, “Activities that used to be pleasurable are no longer gratifying (item 
6)”. In contrast, those in which change appears less probable 
are: “Lately I have found that many experiences make me unhappy 
(item 2)”, “The activities I engage in usually have positive consequences 
(item 10)”, “I am satisfied with my accomplishments (item 8)”. These    
results have clear clinical implications. It can be concluded 
that, when dealing with emotional disorders in breast cancer 
survivors, it would be more effective and efficacious to focus 
the first sessions of the intervention on that condition which 
can be more easily modified (according to items 5, 9 and 6), 
that is, on promoting an increase in rewarding activities 
which ensure the availability of environmental rewards. 
However, ultimately, the efficacy of the intervention depends 
on being able to modify also those conditions which are less 
probable to change (according to our results, items 2, 10, 8) 
as this would imply that subjects had acquired competences 
to ensure the contingent reinforcement of their actions. 
These findings are totally coherent with the principles and   
procedures of behavioral therapies of depression, and in   
particular of Behavioral Activation (Lejuez et al., 2001; Mar-
tell et al., 2001). From the very first sessions, this therapy   
establishes a program of rewarding activities which are     
consistent with the person’s values with a view to facilitating 
an increase in RCPR. As in any contextual therapy, the       
ultimate aim is to provide the person with competences 
which enable him/her to identify and change those response 
patterns which lead to depression and/or anxiety. For that 
reason, special attention is paid to identifying and modifying 
strategies of behavioral avoidance. Avoidance patterns       
distance the person from those day-to-day situations on 
which his/her rewards depend and reduce the possibilities of 
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undertaking other healthier strategies of interaction with the 
environment (Bardeen, 2015; Trindade, Ferreira & Pinto-
Gouveia, 2017).  
A similar interpretation can be made of the strong and      
negative correlation of this measure with measures of       
depression (HADS-D, BSI-D; BDI-IA-SCA), of behavioral 
avoidance (AAQ-II, BADS-A/R, BADS-WSI, BADS-SI) 
and of anxiety (HADS-A, BSI-A). There is an equally strong, 
but positive, correlation with measures of activation (BADS-
T). These results coincide with those reported by other     
authors, who, with different clinical populations and general 
population, have identified a relationship between depression 
and RCPS (Folke & Kanter, 2016; Hill, Buitron, & Pettit, 
2017), and between patterns of behavioral avoidance and 
emotional state (Brem, Shorey, Anderson, & Stuart, 2017; 
González-Fernández et al., 2017). Both conditions, as    
pointed out previously, are principal objectives of behavioral 
therapies for depression. Consequently, we suggest that the 
EROS could also be a suitable instrument for evaluating the 
results of behavioral treatment of emotional disorders in 
breast cancer survivors. This belief is also supported by the 
results, which confirm that participants with and without 
emotional problems differ with regard to their levels of    
perceived environmental reward. Furthermore, as predicted 
by the model on which the scale is based, the particularly 
large effect size of the differences between the scores of   
survivors with and without depression are especially     
noteworthy. 
In our study, the Information Function of the EROS   
indicates that it would be for those breast cancer survivors 
with a score around the mean of the population               
(approximately between 17 and 27) for whom the scale 
would best estimate perception of available environmental 
reinforcement. It is precisely within this range that the cut-
off point for depression (25) is extremely sensitive and most 
specific. The use of the Hospital Anxiety and Depression 
Scale as a gold standard measure is endorsed by its         
properties and by its widespread application in evaluating 
emotional distress free from the bias of physical             
symptomatology. Walker et al. (2007) found somatic      
symptoms of depression to be confounding factors in       
patients with medical illnesses. The same could occur in   
cancer survivors. It is, nevertheless, true that some authors 
have questioned the suitability of this instrument for                 
differentiating between depression and anxiety (Burns, Ho-
fer, Curry, Sexton, & Doyle, 2014). In light of the lack of 
other studies into this matter, one possible subject of future 
study could be the use of other measures and/or procedures 
of clinical diagnosis as gold standard comparison criteria for 
confirming the adjustment of cut-off points in the EROS.  
The degree of similarity shown between the survivors’ 
experiences during the oncological process would suggest 
that the results of this study could be extended to other   
cancer patient populations. However, the fact that this   
population is mainly female raises the question of whether 
the same observations could be applied to a population of 
male survivors. Although it appears unlikely that gender 
would affect the unidimensional structure of the scale, as has 
been shown in previous validation studies using samples with 
an adequate representation of both men and women, it could 
affect the scores. It is known that women suffer from 
and/or seek help for more emotional distress than men     
(Kuehner, 2017). In oncological survivors, gender has also 
been related to different levels of depression (Bevilacqua et 
al., 2018), emotional distress and fear of a relapse (Koch-
Gallenkamp et al., 2016). Furthermore, some studies suggest 
that women appear to be more sensitive to reinforcement 
and rewards (Ryba & Hopko, 2012; Tull, Gratz, Latzman, 
Kimbrel, & Lejuez, 2010). To sum up, due to the great    
clinical value that use of this scale appears to have with on-
cological patients, and also in order to gain more profound 
insights into the relationships between RCPR and emotional 
distress, it would be of interest to carry out further studies 
using adequately-balanced samples in terms of gender and at 
different stages of different types of cancer. In order to 
overcome some of the limitations of this study, it would be 
recommendable to use a longitudinal evaluation design to 
examine the guarantees offered by the instrument.  
 
Conclusion 
 
The EROS is shown to be a valid and reliable measure for 
the evaluation of environmental rewards in breast cancer 
survivors. Its use is recommended for estimating the degree 
of loss of contact with reinforcers of day-to-day life which 
patients undergo as a result of the oncological treatment and 
disease and which increase the probability of emotional   
disorders. 
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